Offering mifepristone as an abortion option

Helen C. Pymar; Mitchell D Creinin

Offering mifepristone as an abortion option

Research output: Contribution to journal › Article › peer-review

Abstract

While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.

Original language	English (US)
Pages (from-to)	113-119
Number of pages	7
Journal	Emergency Medicine
Volume	46
Issue number	2
State	Published - Feb 2001
Externally published	Yes

ASJC Scopus subject areas

Emergency Medicine
Emergency Medical Services

Fingerprint Dive into the research topics of 'Offering mifepristone as an abortion option'. Together they form a unique fingerprint.

Cite this

@article{ac6e905a58344ddf8ff827a0d8d2ab56,

title = "Offering mifepristone as an abortion option",

abstract = "While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.",

author = "Pymar, {Helen C.} and Creinin, {Mitchell D}",

year = "2001",

month = feb,

language = "English (US)",

volume = "46",

pages = "113--119",

journal = "Emergency Medicine",

issn = "0013-6654",

publisher = "Quadrant Healthcom Inc.",

number = "2",

}

TY - JOUR

T1 - Offering mifepristone as an abortion option

AU - Pymar, Helen C.

AU - Creinin, Mitchell D

PY - 2001/2

Y1 - 2001/2

N2 - While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.

AB - While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.

UR - http://www.scopus.com/inward/record.url?scp=0004718253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0004718253&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0004718253

VL - 46

SP - 113

EP - 119

JO - Emergency Medicine

JF - Emergency Medicine

SN - 0013-6654

IS - 2

ER -

Offering mifepristone as an abortion option

Abstract

ASJC Scopus subject areas

Other files and links

Cite this